Depressive Disorders in Schizophrenia
نویسنده
چکیده
146 cases of schizophrenia, fulfilling Research Diagnostic Criteria and a regular followup of 6 months or more, were studied concerning depressive mood disorders at the onset of illness and over a period of time following neuroleptic treatment. There was no significant difference in the total number of cases depressed at the onset of illness (49) and at final follow up (56). Following 8 weeks of neuroleptic treatment, depressive symptoms disappeared in 47 per cent of the depressed schizophrenics and these cases did not evince depression subsequently. However, 53 per cent of schizophrenics manifesting depression at final followup had no depressive symptoms at the onset of illness and in these cases depression occurred following neuroleptic treatment. It is contended that depression may be intrinsic of schizophrenia and neuroleptics may have a role in the causation of depressive disorders in schizophrenia.
منابع مشابه
A Comparison of Selective Attention Processing in Major Depressive Disorder and Schizophrenia
Objective: Cognitive deficits play an important role in differential diagnostics, prognosis and rehabilitation of people with psychological disorders. Attention problems have profound impact on the therapeutic response, risk of relapse, function and quality of life in people with major depressive disorder and schizophrenia. This study compared selective attention of people with schizophrenia, M...
متن کاملتوانایی افتراق بویایی در اختلالهای طیف اسکیزوفرنیا
AbstractObjectives: The aim of this project was a two fold one was to compare the olfactory identifica-tion ability in patients with schizophrenia or schizotypy with that of the patients with mood dis-orders as well as the normal subjects the other was to assess any possible changes after treatment in olfactory identification ability in patients with schizophrenia. Method: The subjects of the ...
متن کاملCOMPARISON OF THE QUALITY OF LIFE IN PATIENTS WITH MAJOR DEPRESSION AND SCHIZOPHRENIA IN THE PARTIAL RECOVERY PHASE
Background & Aims: Schizophrenia and major depression are among severe and chronic psychiatric disorders that affect the most important area of a person's life, namely quality of life. Quality of life is very important in patients with chronic psychiatric disorders and is still low even after partial recovery. Today, quality of life is considered as one of the most important consequences of tre...
متن کاملEfficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial
Background: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia.Methods: In a double-blinded, placebo-controlled, randomized trial (IRCT registration # 201112125280N7), in ...
متن کاملDuration of Hospital Stay in Alcohol/Substance Addictions and Psychiatric Disorders: A 12-Year Retrospective Analysis
Background: Mental disorders are generally a significant reason for increased morbidity. They constitute a serious disease burden. One of the main reasons for this disease burden is long hospitalization periods. Objective: The current study investigated the length of hospital stay and the variables affecting it in patients treated in the Gazi University H...
متن کاملتأثیر ربوکستین در درمان افسردگی کودکان و نوجوانان: یک مطالعه کلینیکی آیندهنگر
Background: Depressive disorders in children and adolescents are chronic and highly morbid. Few studies are carried out on antidepressant drugs for depressed youths, especially specific noradrenergic agents. Reboxetine is a selective norepinephrine reuptake inhibitor. This study was designed to evaluate the effect of reboxetine in childhood and adolescent depression. Methods: Twenty patients of...
متن کامل